期刊文献+

保列治联合哈乐治疗高龄BPH 126例疗效观察

下载PDF
导出
摘要 目的研究保列治和哈乐联合用药治疗高龄患者良性前列腺增生的有效性和安全性。方法联合用药6个月以上的高龄BPH患者126例,统计分析患者前列腺体积、症状评分、残余尿量、尿流率变化。结果联合用药6个月见显效,前列腺体积缩小,最大尿流率增加,国际前列腺症状评分下降,残余尿量下降。结论联合用药治疗高龄BPH患者,能明显改善症状,提高生活质量,长期用药安全性较好。
出处 《中国医药指南》 2013年第9期235-236,共2页 Guide of China Medicine
  • 相关文献

参考文献4

  • 1顾方六.良性前列腺增生流行病学[M]//顾方六.现代前列腺病学,北京:人民军医出版社,2002:3212.
  • 2Chatelain C,Denis L,Foo KT,et al.Recommendations of theInternational Scientific Committee:Evaluation and Treatmentof Lower Urinary Tract Symptoms(LUTS)in Older Men[C].International Consultation on BPH,2011.
  • 3PaIel AK,Chapple CR.Benign prostatic hyperplasia:treatment inprimary care[J].BMJ,2006,333(7567):535-539.
  • 4周振星,徐勋,周昭贤.保列治联合哈乐治疗良性前列腺增生3年疗效观察[J].河北医学,2005,11(2):140-142. 被引量:3

二级参考文献5

  • 1McConnell J D, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia [ J ]. N Engl Med, 1998,338 : 557 - 557.
  • 2Andersen J T,Nickel J C,Marshall V R,et al. Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomtomatic benign prostatic hyperplasia[ J ]. Urology, 1997,49:839 - 839.
  • 3Marberger N J,Anderser J T, Nickel C, et al. Prostate voltune and serum prostate- specific antigen as predictors of acute urinary retention:combined experience from three lathe multinational placbe - controlled trials [ J ]. Eur Urol, 2000,38:563 - 563.
  • 4Hudson P B, Boake R, Trachtenberg J, et al. Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years [ J ]. Urology, 1999,53 : 690 -839.
  • 5马腾骧.现代泌尿外科学[M].天津:天津科学技术出版社,2000.697-710.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部